Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.
PACE Large Co Value Equity A PCPAX
- NAV / 1-Day Return 20.65 / +0.78 %
- Total Assets 789.3 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.130%
- Distribution Fee Level Above Average
- Share Class Type Front Load
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 1.60%
- Turnover 42%
USD | NAV as of Apr 23, 2024 | 1-Day Return as of Apr 23, 2024, 10:14 PM GMT+0
Morningstar’s Analysis PCPAX
Will PCPAX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 34.6
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Merck & Co Inc | 4.22 | 21.1 Mil | Healthcare |
JPMorgan Chase & Co | 3.94 | 19.7 Mil | Financial Services |
UnitedHealth Group Inc | 3.57 | 17.8 Mil | Healthcare |
Unilever PLC ADR | 3.49 | 17.4 Mil | Consumer Defensive |
Rio Tinto PLC ADR | 3.36 | 16.8 Mil | Basic Materials |
Gilead Sciences Inc | 3.31 | 16.5 Mil | Healthcare |
Gaming and Leisure Properties Inc | 3.24 | 16.2 Mil | Real Estate |
Pfizer Inc | 3.20 | 16.0 Mil | Healthcare |
General Dynamics Corp | 3.20 | 16.0 Mil | Industrials |
Philip Morris International Inc | 3.08 | 15.4 Mil | Consumer Defensive |